Covishield疫苗预防Covid-19有效性的检测阴性病例对照研究
在印度Puducherry本机构医护人员中采用检测阴性病例对照设计,匹配年龄和检测日期,共360对病例对照,用多因素条件logistic回归计算比值比。Covishield疫苗一剂和二剂预防实验室确诊Covid-19的疫苗有效性分别为49%(95%CI:17%-68%)和54%(27%-71%);在需要氧疗的中度严重病例中,任意剂次疫苗有效性为95%(44%-100%)。结论为Covishield疫苗对Covid-19有显著保护作用,对重症保护率更高。
要点
- Covishield疫苗一剂预防Covid-19的疫苗有效性为49%(95%CI:17%-68%)。
- Covishield疫苗二剂预防Covid-19的疫苗有效性为54%(95%CI:27%-71%)。
- 需要氧疗的中度严重病例中,任意剂次疫苗有效性为95%(95%CI:44%-100%)。
核心结论
- Covishield疫苗对Covid-19有显著保护作用,对重症形式的保护率更高。
研究设计与样本
- 采用检测阴性病例对照设计,研究对象为印度Puducherry本机构医护人员中的Covid-19病例,并按年龄和检测日期匹配等量对照。
- 使用多因素条件logistic回归计算比值比(OR),疫苗有效性(VE)按100×(1-调整OR)%计算。
- 分析纳入360对病例对照。
主要发现
- 一剂疫苗预防Covid-19的VE为49%(95%CI:17%-68%)。
- 二剂疫苗预防Covid-19的VE为54%(95%CI:27%-71%)。
- 在需要氧疗的中度严重疾病病例中,任意剂次疫苗的VE为95%(95%CI:44%-100%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aimed at assessing the vaccine effectiveness (VE) of Covishield, which is identical to AstraZeneca vaccine, in preventing laboratory-confirmed Covid-19. METHODS: Using test-negative case-control design, information on vaccination status of cases with Covid-19 among healthcare workers in our institution in Puducherry, India, and an equal number of controls matched for age and date of testing, was obtained. The groups were compared using multivariable conditional logistic regression to calculate odds ratios (OR). VE was calculated as 100*(1-adjusted odds ratio)%. RESULTS: Using data from 360 case-control pairs, VE of one dose and of two doses, in providing protection against Covid-19 was 49% (95% CI: 17%-68%) and 54% (27%-71%), respectively. Among cases with moderately severe disease that required oxygen therapy, VE following any number of vaccine doses was 95% (44%-100%). CONCLUSION: Covishield vaccine protected significantly against Covid-19, with a higher protection rate against severe forms of disease.
引用
- Pramod S, Govindan D, Ramasubramani P, et al. Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study. Vaccine. 2022. PMID: 35168838. doi:10.1016/j.vaccine.2022.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。